Summary &horbar; Control of growth and differentiation during mammalian embryogenesis may be regulated by growth factors. With the use of a very sensitive method, the reverse transcription-polymerase chain reaction, expression of some growth factor transcripts was examined during ovine peri-implantation development. Transcripts for transforming growth factor-a (TGF-a) were found in day 15 to day 30 conceptuses, and in uterine tissues. Epidermal growth factor (EGF) was not detectable in any ovine stages or tissues studied. TGF-a could be the normal physiological ligand for the epidermal growth factor receptor present on the trophoblastic tissues, and its expression pattern suggests an autocrine and paracrine role in the growth and differentiation of ovine embryos.
INTRODUCTION
Development is a series of processes that includes cell proliferation, differentiation, migration and invasion. One set of molecules that seems to have a central role in regulating all of these processes is the polypeptide growth factors. The presence of functional epidermal growth factor receptors (EGF-R) in ovine trophoblastic tissues (Gharib-Hamrouche et al, 1993) suggests that epidermal growth factor (EGF) or EGFrelated proteins could be involved in embryonic and fetal development. The role of EGF in morphogenetic events and differentiation has been studied in several animal species. EGF stimulates proliferation of embryonic cells in culture (Yoneda and Pratt, 1981 ; Kaplowitz et al, 1982) and during morphogenesis (Goldin and Opperman, 1980; Pratt, 1980) . The transforming growth factor-a (TGF-a), which is an EGF-related growth promoting polypeptide, binds to and interacts through the EGF-receptor (Massagu6, 1983; Downward et al, 1984) . It was first discovered from culture of murine sarcoma virus-transformed cells and was later isolated from culture of various tumor cells (DeLarco and Todaro, 1978; Todaro et al, 1980) . Recently, TGF-a has been demonstrated in normal adult tissues, such as bovine pituitary (Samsoondar et al, 1986) , normal epithelial skin keratinocytes (Coffey et al, 1987) , regenerating rat liver (Mead and Fausto, 1989) , and brain (Kudlow et al, 1989) . Since TGF-a, but not EGF, is also found in the preimplantation mouse embryo and in several embryonic midgestational mouse tissues (Rappolee et al, 1988a, Wilcox and Derynck, 1988) , it is possible that TGF-a represents a fetal analog of EGF, which is normally expressed in stem cells and becomes inappropriately overexpressed in transforming cells (Derynck, 1988 (Gubler and Hoffman, 1983 
DNA blot analysis
In order to confirm the identity of the PCR products, DNA bands separated on agarose gel were transferred to Zeta-Probe nylon membrane (Bio Rad, USA) as described by Reed and Mann (1985) and probed with the appropriate sequence according to Maniatis et al (1982) by the following protocol: gels were treated at ambient temperature, successively with HCI 0.25 M for 10 min, NaOH 0.5 M for 30 min and Tris-HCI 0.5 M NaCl 3 M, pH 7.4 for 30 min. The gels were then incubated in contact with nylon membrane overnight in 10 SSC (1 SSC: 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0). Zeta-bind fig 1A) and uterine tissue (fig 1 B) . The identity of the expected 243 bp PCR fragment was confirmed by Southern blot analysis (fig 2) .
The most significant result of the PCR was to obtain a dominant TGF-a product of the predicted length (175 bp). From these results, it was apparent that TGF-a was expressed in the embryo ( fig 3A) and the trophoblast ( fig 3B) . The (Derynck et al, 1984) and rat (Lee et al, 1985) (Rappolee etal, 1988a, b) , and thereafter Werb (1990) showed that this growth factor was expressed as early as the 4-cell developmental stage by mice embryos. In this study, we cannot precise the stage at which the transcripts are first detectable in sheep, because the great number of blastocysts needed for early investigations. However, Watson et al (1994) recently demonstrated the expression of TGF-a throughout ovine preimplantation development (from the 1-cell zygote to the early cavitation or fully expanded blastocyst). On the other hand, we have established that endometrium at the peri-implantation stages (from day 5 to day 25 of pregnancy) is a source of TGF-a, even if it is not possible to determine whether the uterine epithelial or stromal cells are involved.
Transcripts for EGF were not detected at any developmental stage of the ovine peri-implantation embryo and trophoblast or within the uterine endometrium preparations, according to previous bovine and ovine preimplantation investigations (Watson et al, 1992 (Watson et al, , 1994 . However, the expected 247 bp band was not only observed with cDNA derived from human salivary gland total RNA (our study), but also in a homologous system using ovine ovary RNA preparation (Watson et al, 1992) .
The detection of TGF-a mRNA supposes but does not prove peptide secretion by the tissues examined. It is well known that TGF-a is a cleavage product of a 160 amino-acid transmembrane polypeptide: the pro-TGF-a (Derynck et al, 1984; Lee et al, 1985) . The TGF-a sequence starts with residue 40 in the extracellular domain of pro-TGF-a, but the proteolytic process that releases mature TGF-a from pro-TGF-a is inefficient in most cell types. Consequently, substantial levels of pro-TGF-a can accumulate on the cell surface. The possibility that membrane pro-TGF-a might be biologically active while anchored on the cell surface has been demonstrated by using genes mutated in vitro to encode non-cleavable forms of pro-TGF-a (Brachmann et al, 1989; Wong et al, 1989 (Carpenter and Cohen, 1979) , even if non-cleavable pro-TGF-a is less potent than soluble TGF-a as an activator of EGF receptors. Given its high affinity for the EGF receptor, membrane pro-TGF-a may act as a mediator of cell-cell homing and adhesion. This function has been demonstrated by co-culturing non-adherent EGF receptor-expressing cells with cell monolayers expressing pro-TGF-a (Anklesaria et al, 1990) . Thus, a membrane-anchored growth factor precursor and its receptor can funtion simultaneously as mediators of cell-cell adhesion and as initiators of mitogenic stimulation by cell-cell contact. Cleavage of pro-TGF-a is not aimed at generating the active form of the factor but at switching between 2 active forms, a membrane-bound and a diffusible form (Massagu6, 1990; Massagud and Pandiella, 1993) . The regulation of this step would dictate which form of TGF-a is produced by the cell.
Growth factors certainly play a functional role in the development of embryo. In vitro production of bovine preimplantation embryo will help to elucidate the role that growth factor genes play during eutherian preimplantation development. When TGF-! and bFGF are added to bovine embryo medium culture, 39% of the embryos can develop through the 8-cell block compared to 0% for the control group (Larson etal, 1990) . Furthermore, Seidel et al (1991 ) reported that 37% of in vitro-cleaved and matured bovine zygotes can develop to the blastocyst stage in a completely defined medium.
We known that the biological activities induced by EGF are also shared by TGF-a in many responses and TGF-a is even a more potent agent than EGF (Partanen, 1990) . TGF-a affects the rate of mouse embryo development and blastocyst cavity expansion and is thus postulated to act on the first differentiative step of the preimplantation embryo (Dardik and Schultz, 1991 (Werb, 1990) .
TGF-a of uterine origin may have an autocrine effect by increasing proliferation of decidual tissue and stimulating decidual hormone (PRL) production in the rat (Han et al, 1987 
